These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26397159)

  • 1. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
    Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
    Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
    Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
    Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
    Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
    Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
    Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
    Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
    van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
    Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SFRP4 was overexpressed in colorectal carcinoma.
    Huang D; Yu B; Deng Y; Sheng W; Peng Z; Qin W; Du X
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):395-401. PubMed ID: 19730886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
    Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence.
    Cheng LC; Chao YJ; Overman MJ; Wang C-; Phan NN; Chen YL; Wang TW; Hsu HP; Shan YS; Lai MD
    Sci Rep; 2020 Aug; 10(1):13255. PubMed ID: 32764696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells.
    Hughes KR; Sablitzky F; Mahida YR
    Inflamm Bowel Dis; 2011 Jan; 17(1):213-20. PubMed ID: 20848536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
    Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
    Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
    Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
    Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
    Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation of the
    Li H; Zhao J; Sun J; Tian C; Jiang Q; Ding C; Gan Q; Shu P; Wang X; Qin J; Sun Y
    Mol Cancer Res; 2021 Sep; 19(9):1454-1464. PubMed ID: 34016745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.